Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by Gilaaaaon Nov 14, 2014 4:36pm
415 Views
Post# 23131122

PBI-4050 -medical and biology people or any one familiar

PBI-4050 -medical and biology people or any one familiar

From all the studies and the trials it is clear that the data in animals as related to  PBI-4050  is good to very promising.  The big question is how will this process (dealing with  fibrosis ) work with humans. Would this be different, as  this may be a biologic response as opposed to a responds to a compound. I guess that it is most difficult to asses but critical for me if I am to add more to an already stretched position  Any input would help.
thanks
Gilaaaa
Bullboard Posts